AI & Imaging
SubtleHD-CT adds FDA-cleared option for CT enhancement
The clearance covers AI/ML software for processing and enhancing CT images regardless of scanner manufacturer or model, according to FDA records.
Company
Subtle Medical
Business
Subtle Medical raises $33M for AI imaging expansion
The Series C-backed growth capital brings Subtle Medical’s total funding to $86M as the company scales its vendor-neutral AI imaging platform across MRI, PET, and CT.
AI & Imaging
SubtleHD-PET clearance targets low-count PET scans
Subtle Medical said the software can enhance PET images from accelerated acquisitions and supports PET/CT and PET/MR systems across FDA-approved radiotracers.